Patents by Inventor Richard C. Yee

Richard C. Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kinase inhibitors
    Patent number: 8455529
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: June 4, 2013
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Richard C. Yee
  • KINASE INHIBITORS
    Publication number: 20110319460
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: September 9, 2011
    Publication date: December 29, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Julie A. Wurster, Richard C. Yee
  • Kinase inhibitors
    Patent number: 8034957
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: October 11, 2011
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Richard C. Yee
  • Sulfoximines as kinase inhibitors
    Patent number: 7915443
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: March 29, 2011
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Clarence Eugene Hull, III, Richard C. Yee, Sougato Boral, Shimiao Wang, Thomas C. Malone
  • Kinase Inhibitors
    Publication number: 20100168199
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 1, 2010
    Applicant: Allengan, Inc.
    Inventors: Julie A. Wurster, Richard C. Yee
  • Kinase inhibitors
    Patent number: 7692005
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: April 6, 2010
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Edward H. Wang, Richard C. Yee
  • SULFOXIMINES AS KINASE INHIBITORS
    Publication number: 20090099181
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: November 16, 2007
    Publication date: April 16, 2009
    Inventors: Julie A. Wurster, Clarence Eugene Hull, III, Richard C. Yee, Sougato Boral, Shimiao Wang, Thomas C. Malone
  • Indol kinase inhibitors
    Patent number: 7439371
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: July 11, 2006
    Date of Patent: October 21, 2008
    Assignee: Allergan, Inc.
    Inventors: Julie A. Wurster, Richard C. Yee